Sartorius Aktiengesellschaft

Price Chart

Risk-Adjusted Performance

Also Listed On

Sartorius Aktiengesellschaft (SRT3) Price Performance

Sartorius Aktiengesellschaft (SRT3) trades on XETRA (Frankfurt) in EUR. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at EUR211.50, up 2.57% from the previous close.

Over the past year, SRT3 has traded between a low of EUR175.85 and a high of EUR265.30. The stock has lost 3.1% over this period. It is currently 20.3% below its 52-week high.

Sartorius Aktiengesellschaft has a market capitalization of $14.48B, with a price-to-earnings ratio of 93.62 and a dividend yield of 0.34%.

About Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.